inVentiv Medical Management Launches Accountable Care Solutions™

AUGUSTA, Ga., Feb. 1, 2012 /PRNewswire/ -- inVentiv Medical Management, an inVentiv Health company and leading provider of physician-directed, nurse-supported and technology-enabled medical management solutions, announced today the national launch of a series of new solutions that help to prevent the inappropriate and ineffective care often associated with some of the most complex and costly health conditions. With its Accountable Care Solutions™, inVentiv Medical Management provides customers with a dedicated staff of specialty care physicians, nurses and billing experts who use evidence-based standards to evaluate and enhance the delivery of medical care to patients with cancer, cardiovascular and chronic kidney diseases.

Powered by a combination of clinical and financial algorithms and evidence-based decision-making rules, inVentiv Medical Management's Accountable Care Solutions ensure that physician-ordered procedures are the best option from a treatment effectiveness and patient risk perspective. The new suite of solutions includes Comprehensive Oncology Care Management™, Comprehensive Cardiovascular Care Management™ and Comprehensive Kidney Care Management™. These Accountable Care Solutions offer customers – such as third-party administrators, employer groups and reinsurance carriers – best-in-class resources to effectively and efficiently enhance healthcare quality, while reducing overall costs of medical claims and improving patient outcomes.

"Cancer treatments align to evidence-based medicine as little as 30 percent of the time, 20 to 40 percent of the pacemakers doctors implant are medically inappropriate, and many patients living with the dangerous triad of uncontrolled diabetes, hypertension and high cholesterol will wind up with kidney failure and find themselves on dialysis," said Marc Palmer, CEO of inVentiv Medical Management. "Such inappropriate and ineffective care is directly contributing to the rising cost of healthcare in the United States."

Palmer added: "To reduce the risk of inappropriate care, help manage healthcare costs and ensure patients receive the quality care they deserve, inVentiv Medical Management developed Accountable Care Solutions. Using evidence-based guidelines, inVentiv Medical Management's new solutions for comprehensive oncology, cardiovascular and kidney care management help clients verify that treatments are safe and effective before care takes place. At the same time, the solutions also help clients drive efficiencies, reduce costs and ensure patients are getting the most from their healthcare dollars."    

inVentiv's specialty care physicians, nurses and billing experts employ a variety of strategies to rationalize and reduce costs before patients receive treatment. They engage with patients and caregivers to provide support and education, as well as identify resources that improve care. To enhance relationships with healthcare providers, inVentiv specialty physicians offer peer-to-peer consultations and source independent reviews if appeals arise. In addition, billing and certified coding professionals review medical claim forms for errors in coding and highlight trends of abuse or duplicate charges. This approach ensures inVentiv is accountable to patients, providers and medical plans.

About Accountable Care Solutions™
Accountable Care Solutions™, powered by inVentiv Medical Management, provides customers with a dedicated staff of specialty care physicians, nurses and billing experts who use evidence-based standards to evaluate and enhance the delivery of medical care to patients with some of the most complex and costly health conditions. inVentiv's suite of Accountable Care Solutions includes:

• Comprehensive Oncology Care Management™
  Comprehensive Oncology Care Management provides a clinically accountable solution focused on promoting cost-effective, safe and integrated care management for patients living with cancer. The program offers a unique closed-loop solution that includes: prospective clinical review of physician-ordered treatments for alignment with evidence-based medicine; engagement with patients and caregivers to provide support and education and identify resources that improve care; and ongoing surveillance of claims for appropriate quality and cost of care.

• Comprehensive Cardiovascular Care Management™
  Comprehensive Cardiovascular Care Management provides a clinically accountable solution focused on promoting cost-effective, safe and integrated care management for patients affected by cardiovascular disease. The program offers a unique closed-loop solution that includes: prospective review of patient medical status and proposed procedures, determination of medical necessity and pre-negotiation for cost management opportunities; concurrent review during hospitalization to evaluate proposed cardiac interventions; and retrospective review for alignment with medically necessary care and post service negotiation for cost management opportunities.

• Comprehensive Kidney Care Management™
  Comprehensive Kidney Care Management provides a clinically accountable solution focused on promoting cost-effective, safe and integrated care management for patients affected by chronic kidney disease. The program offers a unique closed-loop solution that includes: identification of at risk populations; engagement with patients and caregivers to provide support and education and identify resources that improve care; clinical review of patient medical status and ordered treatment for alignment with national guidelines and prescribing standards; and review of claims and ongoing surveillance for appropriate quality and cost of care.

About inVentiv Medical Management
inVentiv Medical Management (formerly AWAC), an inVentiv Health company,  is a leading national provider of physician-directed, nurse-supported, technology-enabled, medical management solutions to third party administrators, self-funded or fully insured plans, employer groups, managing general underwriters and insurance carriers. With a mission of improving healthcare costs, quality and outcomes, we deliver balanced clinical surveillance and cost intervention that supports payers, providers and patients. inVentiv Medical Management is headquartered in Augusta, Georgia. Please visit www.inVentivMM.com for more information.

About inVentiv Health
inVentiv Health, Inc. is a leading global provider of best-in-class clinical, commercial and consulting services to companies seeking to accelerate performance. inVentiv's client roster includes more than 550 pharmaceutical, biotech and life sciences companies. With 13,000 employees in 40 countries, inVentiv rapidly transforms promising ideas into commercial reality. inVentiv Health Inc. is privately owned by inVentiv Group Holdings Inc., an organization sponsored by affiliates of Thomas H. Lee Partners, L.P., Liberty Lane Partners and members of the inVentiv management team. For more information, visit http://www.inventivhealth.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: the impact of our substantial level of indebtedness on our ability to generate sufficient cash to fulfill our obligations under our existing debt instruments or our ability to incur additional indebtedness; the impact of the consummation of the acquisition anticipated by this release and any future announced acquisitions, and any additional leverage we may incur in connection with the financing thereof, on our ratings and the ratings of our debt securities; our ability to sufficiently increase our revenues and maintain or decrease expenses and cash capital expenditures to permit us to fund our operations; our ability to continue to comply with the covenants and terms of our senior secured credit facilities and to access sufficient capital under our credit agreement or from other sources of debt or equity financing to fund our operations; the impact of any default by any of our credit providers or swap counterparties; our ability to accurately forecast costs to be incurred in providing services under fixed price contracts; our ability to accurately forecast insurance claims within our self-insured programs; the potential impact of pricing pressures on pharmaceutical manufacturers from future healthcare reform initiatives or from changes in the reimbursement policies of third-party payers; our ability to grow our existing client relationships, obtain new clients and cross-sell our services; the potential impact of financial, economic, political and other risks, including interest rate and exchange rate risks, related to conducting business internationally; our ability to successfully operate new lines of business; our ability to manage our infrastructure and resources to support our growth; our ability to successfully identify new businesses to acquire, conclude acquisition negotiations and integrate the acquired businesses into our operation, and the resulting synergies; the resolution of purchase price adjustment disputes in connection with our recent acquisitions and related impacts; any disruptions, impairments, or malfunctions affecting software as well as excessive costs or delays that may adversely impact our continued investment in and development of software; the potential impact of government regulation on us and on our client base; our ability to comply with all applicable laws as well as our ability to successfully implement from a timing and cost perspective any changes in applicable laws; our ability to recruit, motivate and retain qualified personnel, including sales representatives; the possibility that client agreements will be terminated or not renewed; any potential impairment of goodwill or intangible assets; consolidation in the pharmaceutical industry; changes in trends in the healthcare and pharmaceutical industries or in pharmaceutical outsourcing, including initiatives by our clients to perform services we offer internally; the potential liability associated with bringing new drugs to market, including potential liability from injury to clinical trial participants; and the actual impact of the adoption of certain accounting standards; our ability to maintain technological advantages in a variety of functional areas, including sales force automation, electronic claims surveillance and patient compliance. Readers of this notice are referred to reports provided to investors from time to time and the offering memorandums provided in connection with the issuance of our senior secured notes for further discussion of these and other factors.

SOURCE inVentiv Medical Management